Guardian Pharmacy Services, Inc (GRDN) Stock Analysis
Healthcare · Medical Care Facilities
Hold if already holding. Not a fresh buy at $42.00, but acceptable to hold if already in. Reasons: Concentration risk — Customer: ALFs and BHFs; Analyst target reached - limited upside remaining.
Guardian Pharmacy Services provides technology-enabled pharmacy dispensing and clinical services to long-term care facilities (LTCFs), operating 61 pharmacies serving ~205,000 residents in ~8,400 LTCFs across 38 states. More than two-thirds of annual revenue comes from assisted... Read more
Hold if already holding. Not a fresh buy at $42.00, but acceptable to hold if already in. Reasons: Concentration risk — Customer: ALFs and BHFs; Analyst target reached - limited upside remaining. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Score 5.3/10, moderate confidence.
Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 62d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated 2026-06-09Recent Developments — Guardian Pharmacy Services, Inc
Latest news
- NEWS Guardian Pharmacy Services (GRDN) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance — Yahoo Finance positive
- NEWS Guardian (GRDN) Q1 2026 Earnings Transcript - AOL.com — AOL.com neutral
- NEWS Guardian Pharmacy: Q1 Earnings Snapshot - KING5.com — KING5.com neutral
- NEWS Guardian Pharmacy: Q1 Earnings Snapshot - KVUE — KVUE neutral
- NEWS Earnings call transcript: Guardian Pharmacy Services Q1 2026 results meet EPS expectations - Investing.com Canada — Investing.com Canada positive
Generated 2026-06-09T22:16:35Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHCustomerALFs and BHFs10-K Item 1: 'More than two-thirds of our annual revenue for each of the past three years has been generated from residents of ALFs and BHFs'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $42.00, but acceptable to hold if already in. Reasons: Concentration risk — Customer: ALFs and BHFs; Analyst target reached - limited upside remaining. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Target $41.16 (-2.0%), stop $38.90 (−8.0%), A.R:R -0.7:1. Score 5.3/10, moderate confidence.
Take-profit target: $41.16 (-1.6% upside). Target $41.16 (-2.0%), stop $38.90 (−8.0%), A.R:R -0.7:1. Stop-loss: $38.90.
Concentration risk — Customer: ALFs and BHFs; Analyst target reached - limited upside remaining; Near 52-week high (-0.1% away).
Guardian Pharmacy Services, Inc trades at a P/E of 48.2 (forward 29.8). TrendMatrix value score: 4.6/10. Verdict: Hold.
12 analysts cover GRDN with a consensus score of 4.4/5. Average price target: $43.
What does Guardian Pharmacy Services, Inc do?Guardian Pharmacy Services provides technology-enabled pharmacy dispensing and clinical services to long-term care...
Guardian Pharmacy Services provides technology-enabled pharmacy dispensing and clinical services to long-term care facilities (LTCFs), operating 61 pharmacies serving ~205,000 residents in ~8,400 LTCFs across 38 states. More than two-thirds of annual revenue comes from assisted living facilities (ALFs) and behavioral health facilities (BHFs); the company claims ~13.0% national market share in the ALF/memory care LTCF pharmacy segment.